Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

TAGAMET Drug Profile

« Back to Dashboard

Which patents cover Tagamet, and what substitute generic drugs are available?

Tagamet is a drug marketed by Glaxosmithkline and Medtech Products and is included in six NDAs.

The generic ingredient in TAGAMET is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.

Summary for Tradename: TAGAMET

Patents:0
Applicants:2
NDAs:6
Bulk Api Vendors: see list91
Clinical Trials: see list2
Patent Applications: see list658
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TAGAMET at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Medtech Products
TAGAMET HB
cimetidine
TABLET;ORAL020238-001Jun 19, 1995DISCNYesNo► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-005Apr 30, 1986DISCNNoNo► Subscribe► Subscribe
Medtech Products
TAGAMET HB
cimetidine
TABLET;ORAL020238-002Aug 21, 1996OTCYesYes► Subscribe► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: TAGAMET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline
TAGAMET
cimetidine hydrochloride
SOLUTION;ORAL017924-001Approved Prior to Jan 1, 19824,024,271► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-002Approved Prior to Jan 1, 19823,950,333► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-004Dec 14, 19833,950,333► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-004Dec 14, 19834,024,271► Subscribe
Glaxosmithkline
TAGAMET
cimetidine
TABLET;ORAL017920-005Apr 30, 19864,024,271► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc